Search by Drug Name or NDC
NDC 50419-0524-35 Betaseron Details
Betaseron
Betaseron is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bayer HealthCare Pharmaceuticals Inc.. The primary component is .
MedlinePlus Drug Summary
Interferon beta-1b injection is used to reduce episodes of symptoms in patients with relapsing-remitting (course of disease where symptoms flare up from time to time) of multiple sclerosis (MS, a disease in which the nerves do not function properly and patients may experience weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control). Interferon beta-1b is in a class of medications called immunomodulators. It is not known exactly how interferon beta-1b works to treat MS.
Related Packages: 50419-0524-35Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Interferon Beta-1b Injection
Product Information
NDC | 50419-0524 |
---|---|
Product ID | 50419-524_8028db70-d490-4d61-94ad-0220b25df27a |
Associated GPIs | 62403060506420 |
GCN Sequence Number | 062602 |
GCN Sequence Number Description | interferon beta-1b KIT 0.3 MG SUBCUT |
HIC3 | H0E |
HIC3 Description | AGENTS TO TREAT MULTIPLE SCLEROSIS |
GCN | 98376 |
HICL Sequence Number | 008537 |
HICL Sequence Number Description | INTERFERON BETA-1B |
Brand/Generic | Brand |
Proprietary Name | Betaseron |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | interferon beta-1b |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA103471 |
Listing Certified Through | 2024-12-31 |
Package
NDC 50419-0524-35 (50419052435)
NDC Package Code | 50419-524-35 |
---|---|
Billing NDC | 50419052435 |
Package | 14 CARTON in 1 BOX (50419-524-35) / 1 KIT in 1 CARTON (50419-524-01) * 1 mL in 1 VIAL, SINGLE-USE * 1.2 mL in 1 SYRINGE |
Marketing Start Date | 2009-08-11 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 677.501 |
Pricing Unit | EA |
Effective Date | 2024-01-01 |
NDC Description | BETASERON 0.3 MG KIT |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 4 |
Classification for Rate Setting | B |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis